Home » Topics » BioWorld Science

BioWorld Science
RSS

First patient enrolled in phase IIb trial of AmnioFix Injectable for the treatment of OA of the knee

March 29, 2018

Edge Therapeutics discontinues phase III NEWTON 2 study of EG-1962

March 29, 2018

FDA grants orphan drug designation to CYP-001

March 29, 2018

The University of Saskatchewan divulges alpha-synuclein aggregation inhibitors

March 29, 2018

GlaxoSmithKline presents novel viral 3C and 3CL protease inhibitors

March 29, 2018

New mu-opioid receptor agonists identified at Mebias Discovery

March 29, 2018

Nabriva Therapeutics and Roivant Sciences enter lefamulin license agreement

March 29, 2018

Incyte patents novel MAP4K1 inhibitors

March 29, 2018

Mylan to introduce new triple combo once-daily HIV treatment in U.S.

March 29, 2018

Preliminary phase I pharmacokinetic data reported for AZD-8186

March 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...